Lyka Labs Ltd
Lyka Labs Ltd (LYKALABS) last traded at ₹76.4, a market capitalisation of ₹276 crore. Over the past 52 weeks the stock has ranged between ₹44.1 and ₹105. Lyka Labs Ltd last reported results for the quarter ended Jun 2026, with sales of ₹42.31 crore and net profit of ₹2.05 crore. Figures are as of 25 Aug 2026 and are not real time.
Lyka Labs Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Lyka Labs Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹42.31 cr, up 28.1% from ₹33.03 cr a year earlier. Net profit was ₹2.05 cr, up 107.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 41.16 | 33.8 | 33.43 | 33.03 | 36.66 | 30.73 | 28.03 | 42.31 |
| Expenses | 36.21 | 28.61 | 29.35 | 29.35 | 39.2 | 29.08 | 34.48 | 37.76 |
| Operating profit | 4.95 | 5.19 | 4.08 | 3.68 | -2.54 | 1.65 | -6.45 | 4.55 |
| OPM % | 12.03% | 15.36% | 12.20% | 11.14% | -6.93% | 5.37% | -23.01% | 10.75% |
| Other income | 0.03 | 0.83 | 0.82 | 0.63 | 1.09 | 1.16 | 0.61 | 0.42 |
| Interest | 0.54 | 0.61 | 0.47 | 0.85 | 0.79 | 0.82 | 0.7 | 1.01 |
| Depreciation | 1.76 | 1.83 | 1.42 | 2.11 | 2.15 | 2.15 | 2.04 | 2.01 |
| Profit before tax | 2.68 | 3.58 | 3.01 | 1.35 | -4.39 | -0.16 | -8.58 | 1.95 |
| Tax % | 28.36% | 24.30% | 32.89% | 26.67% | -26.65% | -6.25% | -6.06% | -5.13% |
| Net profit | 1.91 | 2.7 | 2.03 | 0.99 | -3.22 | -0.15 | -8.07 | 2.05 |
| EPS (₹) | 0.59 | 0.76 | 0.50 | 0.26 | -0.94 | 0.00 | -2.13 | 0.57 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Lyka Labs Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 86 | 194 | 93 | 111 | 138 | 128 | 138 |
| Operating profit | 20 | 101 | 17 | 16 | 18 | -3 | -3 |
| OPM % | 23% | 52% | 18% | 14% | 13% | -2.7% | -2.0% |
| Net profit | -10 | 38 | -13 | -3 | 8 | -10 | -9 |
| EPS (₹) | -4.03 | 13.59 | -4.30 | -0.75 | 2.24 | -2.81 | -2.50 |
TTM is the trailing twelve months to the most recent quarter.
Lyka Labs Ltd growth and returns
- 10 Years
- 0%
- 5 Years
- 8%
- 3 Years
- 11%
- TTM
- -3%
- 10 Years
- %
- 5 Years
- 1%
- 3 Years
- -32%
- TTM
- -219%
- 10 Years
- 1%
- 5 Years
- 0%
- 3 Years
- -15%
- 1 Year
- -25%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -2%
- Last Year
- -10%
Lyka Labs Ltd shareholding pattern
Promoters held 58.45% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.17% and DIIs 0.66%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 58.11% | 58.11% | 58.16% | 58.16% | 58.16% | 58.16% | 58.16% | 58.45% |
| FIIs | 0.15% | 0.15% | 0.24% | 0.16% | 0.17% | 0.17% | 0.29% | 0.17% |
| DIIs | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% |
| Public | 41.08% | 41.07% | 40.93% | 41.02% | 40.99% | 40.99% | 40.89% | 40.73% |
| No. of shareholders | 28,943 | 29,099 | 28,472 | 28,189 | 27,743 | 27,155 | 26,727 | 29,369 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Lyka Labs Ltd corporate filings
- Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Lyka Labs Ltd has fulfilled its regulatory obligation under Regulation 30 of the SEBI…
Read the full analysis - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAGM/EGMlow impact
Cruxal's analysis: Lyka Labs Limited has successfully concluded its 47th Annual General Meeting held on 10th…
Read the full analysis - Revised Press Release On Unaudited Financial Results For The Q1 June, 2026Company Updatehigh impact
Cruxal's analysis: Lyka Labs Limited has released its unaudited financial results for the quarter ended June…
Read the full analysis - Shareholder Meeting / Postal Ballot-Outcome of AGMAGM/EGMlow impact
Cruxal's analysis: Lyka Labs Limited has successfully concluded its 47th Annual General Meeting held on 10th…
Read the full analysis - Press Release For Unaudited Financial Results Of Q1 June 2026Company Updatehigh impact
Cruxal's analysis: Lyka Labs Limited has announced robust financial results for Q1 FY27, with consolidated…
Read the full analysis - Board Meeting Outcome for Outcome Of The Board Meeting Dated 10Th August, 2026Board Meetinghigh impact
Cruxal's analysis: Lyka Labs Limited reported a turnaround in Q1 FY2027 with a standalone net profit of 2.10…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Lyka Labs Ltd
Cruxal reads every Lyka Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.